Alicia Secor's Insider Trades & SAST Disclosures
Alicia Secor's most recent trade in G1 Therapeutics Inc was a trade of 30,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Sept. 18, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Alicia Secor.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| G1 Therapeutics Inc | Alicia Secor | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Sep 2024 | 30,000 | 0 | - | - | Stock Option (right to buy) | |
| G1 Therapeutics Inc | Alicia Secor | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Sep 2024 | 30,000 | 0 | - | - | Stock Option (right to buy) | |
| G1 Therapeutics Inc | Alicia Secor | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Sep 2024 | 30,000 | 0 | - | - | Stock Option (right to buy) | |
| G1 Therapeutics Inc | Alicia Secor | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Sep 2024 | 20,000 | 10,000 (0%) | 0% | - | Common Stock | |
| G1 Therapeutics Inc | Alicia Secor | Director | 18 Sep 2024 | 10,000 | 0 (0%) | 0% | - | Common Stock | ||
| G1 Therapeutics Inc | Alicia Secor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 30,000 | 30,000 | - | - | Stock Options (Right to Buy) | |
| G1 Therapeutics Inc | Alicia Secor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 10,000 | 30,000 (0%) | 0% | 0 | Common Stock | |
| G1 Therapeutics Inc | Alicia Secor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 30,000 | 30,000 | - | - | Stock Options (Right to Buy) | |
| G1 Therapeutics Inc | Alicia Secor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 10,000 | 20,000 (0%) | 0% | 0 | Common Stock | |
| G1 Therapeutics Inc | Alicia Secor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2022 | 30,000 | 30,000 | - | - | Stock Options (Right to Buy) | |
| G1 Therapeutics Inc | Alicia Secor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2022 | 10,000 | 10,000 (0%) | 0% | 0 | Common Stock | |
| G1 Therapeutics Inc | Alicia Secor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 52,320 | 52,320 | - | - | Stock Options (Right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges